Over 6 million women in the U.S. suffer from endometriosis, a chronic condition often misdiagnosed, leading to an average of 5 to 7 years before an accurate diagnosis. But a new test could help women ...

The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...

Low levels of a particular compound in faeces could be a sign of endometriosis – and supplementation of that compound might even help control the condition. Affecting nearly 200 million people ...

If you are having digestive symptoms, your doctor may prescribe an at-home stool test, in which you collect stool samples and send them to a lab or bring them to your doctor’s office for analysis.

Pancreatic elastase is the digestive enzyme the pancreas produces to help digest food. Doctors can measure elastase levels by testing a stool sample. Low levels could indicate exocrine pancreatic ...

Exocrine pancreatic insufficiency (EPI) causes clay-colored, greasy stools that smell foul. A stool test to check for low levels of the elastase enzyme can help diagnose the condition. The pancreas ...

42 Technology (42T), FIND, the global alliance for diagnostics, and Rutgers University (Rutgers) have worked together to develop an innovative stool sample processing kit that has played a central ...

Experts say doing the stool sample tests every year is as accurate at detecting colorectal cancer as a colonoscopy every 10 years. Share on Pinterest The at-home stool sample tests are inexpensive and ...

A stool ova and parasite, or O&P, test is a simple way of diagnosing parasite infections. This test determines whether parasites and their eggs are present in your stool. The stool O&P test is a ...

Using just a stool sample, doctors may be able to detect colon and many other cancers of the digestive tract including stomach, pancreatic, bile duct and esophageal cancer, U.S. researchers said on ...

The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.